S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
Experts: NVIDIA Now "Too Big to Succeed" (Ad)
MarketBeat Week in Review – 9/18 - 9/22
The federal government is headed into a shutdown. What does it mean, who's hit and what's next?
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Auto workers still have room to expand their strike against car makers. But they also face risks
His system isolated NVIDIA - Here's His Next Buy. (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
Experts: NVIDIA Now "Too Big to Succeed" (Ad)
MarketBeat Week in Review – 9/18 - 9/22
The federal government is headed into a shutdown. What does it mean, who's hit and what's next?
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Auto workers still have room to expand their strike against car makers. But they also face risks
His system isolated NVIDIA - Here's His Next Buy. (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
Experts: NVIDIA Now "Too Big to Succeed" (Ad)
MarketBeat Week in Review – 9/18 - 9/22
The federal government is headed into a shutdown. What does it mean, who's hit and what's next?
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Auto workers still have room to expand their strike against car makers. But they also face risks
His system isolated NVIDIA - Here's His Next Buy. (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
Experts: NVIDIA Now "Too Big to Succeed" (Ad)
MarketBeat Week in Review – 9/18 - 9/22
The federal government is headed into a shutdown. What does it mean, who's hit and what's next?
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Auto workers still have room to expand their strike against car makers. But they also face risks
His system isolated NVIDIA - Here's His Next Buy. (Ad)
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
OTCMKTS:PDDPF

Medexus Pharmaceuticals (PDDPF) Stock Forecast, Price & News

$2.14
0.00 (0.00%)
(As of 08/4/2023)
Compare
Today's Range
$2.11
$2.42
50-Day Range
$2.14
$3.22
52-Week Range
$1.70
$3.99
Volume
39,966 shs
Average Volume
4,355 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

PDDPF stock logo

About Medexus Pharmaceuticals (OTCMKTS:PDDPF) Stock

Medexus Pharmaceuticals, Inc. operates as a pharmaceutical company. It provide healthcare products to Healthcare Professionals and patients and focuses on therapeutic areas of auto-immune disease and pediatrics. The company products include Rasuvo, Metoject and Rupall. Medexus was founded by Sylvain Chretien in January 2008 and is headquartered in Verdun, Canada.

PDDPF Price History

PDDPF Stock News Headlines

BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Stifel Nicolaus Upgrades Medexus Pharmaceuticals Inc (MDP) to Buy
Morning News Call - Canada, June 20
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
See More Headlines
Receive PDDPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:PDDPF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Kenneth d’Entremont
    Chief Executive Officer & Director
  • Roland Boivin
    Chief Financial Officer
  • Michael Pine
    Senior VP-Business Development & Strategy
  • Richard Labelle
    Vice President-Marketing & Sales













PDDPF Stock - Frequently Asked Questions

How have PDDPF shares performed in 2023?

Medexus Pharmaceuticals' stock was trading at $1.54 at the beginning of the year. Since then, PDDPF shares have increased by 39.0% and is now trading at $2.14.
View the best growth stocks for 2023 here
.

What is Medexus Pharmaceuticals' stock symbol?

Medexus Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PDDPF."

How do I buy shares of Medexus Pharmaceuticals?

Shares of PDDPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medexus Pharmaceuticals' stock price today?

One share of PDDPF stock can currently be purchased for approximately $2.14.

How can I contact Medexus Pharmaceuticals?

The official website for the company is www.medexus.com. The company can be reached via phone at (514) 762-2626.

This page (OTCMKTS:PDDPF) was last updated on 9/23/2023 by MarketBeat.com Staff

My Account -